Trial
NCT02849886
T Lymphocytes (LT) Expressing iCASP9 and ΔCD19 in Allogeneic Haematopoietic Transplantation.
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Centre Hospitalier Universitaire de Besancon
Collaborators
Etablissement Français du Sang; Bellicum Pharmaceuticals
Condition
Graft Versus Host Disease
Intervention
T lymphocytes iCASP9 ΔCD19
Why stopped
not enough recruitment because of new therapeutic alternatives
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-09